Antlanger M, Domenig O, Kaltenecker CC, Kovarik JJ, et al. Combined SGLT-2 and ACE inhibition upregulates the renin-angiotensin system in chronic kidney disease with type 2 diabetes: Results of a randomized, double-blind, placebo-controlled exploratory trial. Diabetes Obes Metab 2022 Jan 4. doi: 10.1111/dom.14639.
PMID: 34984822